Transforming Lung Cancer Intervention with Real-Time AI Imaging
At Body Vision Medical, we are redefining the standard of care in lung cancer diagnostics and therapies. Our advanced AI-driven imaging technology enables real-time, high-precision navigation for biopsy and for delivering localized therapies of pulmonary nodules. We empower providers with enhanced accuracy and confidence.
We are committed to innovation and we bridge the gap between early detection and improved patient outcomes, making cutting-edge lung cancer interventions more accessible than ever before.
Navigating Challenges
Navigating deep within the lung to obtain tissue samples for a precise diagnosis and effective treatment plan brings a host of challenges, even for the most experienced providers. The procedure requires not only skill, but consistent accuracy within the highly dynamic environment that is a human lung.
Advanced imaging technology like LungVision® offers the promise to not only improve diagnostic yield, but also the precision providers need to apply localized therapies for treatment.
Solving Challenges
The probability of acquiring a diagnostic tissue sample via bronchoscopy rarely exceeds 70% due to CT-to-Body divergence - the difference between a lesion's preoperative CT location and its actual location during bronchoscopy.
Body Vision’s proprietary AI Tomo® technology corrects for CT-to-Body Divergence and a visual Tool-in-Lesion confirmation can increase provider confidence with diagnostic yields approaching 95%.
"With Body Vision, our ability to correct for CT-to-body divergence, especially in small, sub-centimeter and centimeter lesions is game changing."
Dr. Joseph D. Whitlark
Thoracic Surgeon
Monmouth Medical Center
USA
The LungVision System
Proprietary AI transforms any 2D C-arm into an advanced 3D imaging system with advanced navigation capabilities. It empowers pulmonologists and thoracic surgeons with the real-time, intraoperative imaging they need to accurately locate and biopsy small lung lesions with greater precision and confidence.
“We need vision in the lungs to effectively treat our patients,” he explained, “but in the same sense, we need vision in our room to be able to work effectively as a
team.”
Dr. Seung-hyun Yong
Interventional Pulmonologist
Severance Hospital, Yonsei University
Republic of Korea
The LungVision Benefits
Improved Diagnostic Yield
Elevate diagnostic yield from 55-75% to yields approaching 90% and beyond.
Superior Economics
Increase patient volumes with lower total cost of ownership than alternative solutions.
Global Therapy Delivery
Enable cost-effective and accurate delivery of local therapies throughout the world.
Reduced
Radiation
Better image quality than 3D C-arms at 1/5 the radiation spin-for-spin.
_edited.jpg)
"In most cases, Body Vision provides me with the same confidence as CBCT. Even better, in fact, since I don't need to leave the room. I can keep the scope at the exact position pointing at the lesion and confirm tool-in-lesion right before biopsy."
Dr. Amir Abramovich
Interventional Pulmonologist
Carmel Medical Center
Israel
